FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$13.27
+0.800 (+6.42%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $12.00 $15.18 Wednesday, 1st May 2024 ASMB stock ended at $13.27. This is 6.42% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.45% from a day low at $12.75 to a day high of $13.44.
90 days $0.82 $15.18
52 weeks $0.641 $15.18

Historical Assembly Biosciences prices

Date Open High Low Close Volume
Dec 06, 2023 $0.730 $0.790 $0.726 $0.770 197 860
Dec 05, 2023 $0.725 $0.760 $0.720 $0.753 360 696
Dec 04, 2023 $0.721 $0.750 $0.720 $0.740 205 982
Dec 01, 2023 $0.700 $0.730 $0.700 $0.716 91 901
Nov 30, 2023 $0.720 $0.741 $0.700 $0.700 373 345
Nov 29, 2023 $0.735 $0.765 $0.690 $0.723 444 113
Nov 28, 2023 $0.710 $0.757 $0.705 $0.740 265 759
Nov 27, 2023 $0.711 $0.758 $0.700 $0.720 644 974
Nov 24, 2023 $0.710 $0.740 $0.687 $0.719 1 167 773
Nov 22, 2023 $0.650 $0.693 $0.641 $0.647 605 823
Nov 21, 2023 $0.690 $0.690 $0.644 $0.653 463 166
Nov 20, 2023 $0.718 $0.722 $0.664 $0.671 1 545 730
Nov 17, 2023 $0.689 $0.730 $0.681 $0.720 366 482
Nov 16, 2023 $0.732 $0.760 $0.680 $0.700 385 210
Nov 15, 2023 $0.700 $0.766 $0.691 $0.738 954 181
Nov 14, 2023 $0.701 $0.734 $0.643 $0.689 2 190 230
Nov 13, 2023 $0.740 $0.755 $0.689 $0.700 1 350 988
Nov 10, 2023 $0.779 $0.779 $0.720 $0.745 888 454
Nov 09, 2023 $0.86 $0.87 $0.735 $0.745 1 787 387
Nov 08, 2023 $0.91 $0.92 $0.85 $0.85 475 907
Nov 07, 2023 $0.88 $0.93 $0.86 $0.89 449 308
Nov 06, 2023 $0.90 $0.94 $0.80 $0.88 1 312 142
Nov 03, 2023 $0.88 $0.92 $0.86 $0.87 868 743
Nov 02, 2023 $0.89 $0.90 $0.86 $0.87 613 748
Nov 01, 2023 $0.91 $0.92 $0.88 $0.89 602 848
Click to get the best stock tips daily for free!

About Assembly Biosciences

Assembly Biosciences Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile

Golden Star

Ticker Date Change Price
ETSY Apr 26 1.84% $67.43
DHT Apr 24 1.24% $11.28
LPLA Apr 19 2.49% $262.59
MLI Apr 19 6.77% $52.28
PFLT Apr 18 1.07% $11.25
DOOR Apr 18 0.88% $131.39
LNG Apr 17 0.644% $156.81
FCN Apr 16 2.99% $207.62
ELV Apr 16 4.26% $506.97
ITCI Apr 05 4.92% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT